These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36264285)

  • 21. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm.
    Wang H; Sun L; Bao H; Wang A; Zhang P; Wu X; Tong X; Wang X; Luo J; Shen L; Shao YW; Lu M
    Chin J Cancer Res; 2019 Dec; 31(6):918-929. PubMed ID: 31949394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
    Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
    Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling of gastric neuroendocrine carcinomas.
    Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
    Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
    Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
    PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
    Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
    Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UV Signature Mutations Reclassify Salivary High-grade Neuroendocrine Carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas.
    Sun L; Cliften PF; Duncavage EJ; Lewis JS; Chernock RD
    Am J Surg Pathol; 2019 May; 43(5):682-687. PubMed ID: 30986802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins.
    Qiu MZ; Chen Q; Zheng DY; Zhao Q; Wu QN; Zhou ZW; Yang LQ; Luo QY; Sun YT; Lai MY; Yuan SS; Wang FH; Luo HY; Wang F; Li YH; Zhang HZ; Xu RH
    Cell Rep; 2023 Jun; 42(6):112576. PubMed ID: 37285266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
    Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
    Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.
    Wang Z; Liu C; Zheng S; Yao Y; Wang S; Wang X; Yin E; Zeng Q; Zhang C; Zhang G; Tang W; Zheng B; Xue L; Wang Z; Feng X; Wang Y; Ying J; Xue Q; Sun N; He J
    Cancer Cell; 2024 Jun; 42(6):1106-1125.e8. PubMed ID: 38788718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic and molecular characteristics of neuroendocrine carcinomas of the gallbladder.
    Tang H; Jiang X; Zhu L; Xu L; Wang X; Li H; Gao F; Liu X; Ren C; Zhao Y
    Histol Histopathol; 2024 Jul; ():18788. PubMed ID: 39041213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
    Howitt BE; Dong F; Vivero M; Shah V; Lindeman N; Schoolmeester JK; Baltay M; MacConaill L; Sholl LM; Nucci MR; McCluggage WG
    Am J Surg Pathol; 2020 Nov; 44(11):1541-1548. PubMed ID: 32773531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
    Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
    Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations in gastric amphicrine carcinomas and comparison with gastric mixed neuroendocrine-non-neuroendocrine neoplasms.
    Sun L; Wang C; Zhang J; Shao B; Zhao S; Guo Y; Li X; Sun Y
    Mod Pathol; 2022 Jun; 35(6):808-815. PubMed ID: 34839352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
    Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
    Yu S; Hornick JL; Gonzalez RS
    Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.